首页> 外文期刊>adverse drug reaction bulletin >Drughyphen;induced pulmonary alveolar disease
【24h】

Drughyphen;induced pulmonary alveolar disease

机译:Drughyphen;induced pulmonary alveolar disease

获取原文
       

摘要

A variety of alveolar diseases can be caused by several drugs. The most important diseases, and the drugs that cause them, aremdash;non-cardloccedil;enlc pulmonary oedema: naloxone, intravenous beta2-agonisls, hydrochlorothiazide, desfernoxamine, and more rarely other agents including cytosine arabinoside, carbamazepine, cyclosporin, and haloperidol;Interstitial pneumonltis and lung fibrosis: gold, amiodarone, methotrexate, nitrofurantoin, busulphan, bleomycin, cyclophosphamide, nitrosoureas, sulphasalazine, and, rarely, beta-adrenoceptor blockers:pulmonary eosinophilic: sulphonamides, penicillin, tetracyclines, non-steroidal antiinflammatory drugs, and aminosalicyiates;organizing pneumonia: gold, amiodarone, penicillamine, bleomycin, and sulphasalazine; drug-induced lupus disease: hydralazine, procainamide, sulphasalazine, alphamethyldopa, isoniazid, and phenytoin.pulmonary haemorrhage: poorly controlled anticoagulant therapy and penicillamine therapy.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号